Relief Therapeutics Holding Stock Price History

RLFTY Stock  USD 5.00  0.68  15.74%   
If you're considering investing in Relief OTC Stock, it is important to understand the factors that can impact its price. As of today, the current price of Relief Therapeutics stands at 5.00, as last reported on the 19th of December, with the highest price reaching 5.05 and the lowest price hitting 5.00 during the day. Relief Therapeutics is dangerous given 3 months investment horizon. Relief Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.14, which implies the firm had a 0.14% return per unit of risk over the last 3 months. We were able to interpolate and analyze data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.55% are justified by taking the suggested risk. Use Relief Therapeutics Risk Adjusted Performance of 0.1203, semi deviation of 6.27, and Coefficient Of Variation of 716.01 to evaluate company specific risk that cannot be diversified away.
  
Relief OTC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.143

Best PortfolioBest Equity
Good Returns
Average ReturnsRLFTY
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 10.83
  actual daily
96
96% of assets are less volatile

Expected Return

 1.55
  actual daily
30
70% of assets have higher returns

Risk-Adjusted Return

 0.14
  actual daily
11
89% of assets perform better
Based on monthly moving average Relief Therapeutics is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Relief Therapeutics by adding it to a well-diversified portfolio.

Relief Therapeutics OTC Stock Price History Chart

There are several ways to analyze Relief Stock price data. The simplest method is using a basic Relief candlestick price chart, which shows Relief Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceNovember 12, 20247.71
Lowest PriceSeptember 24, 20242.58

Relief Therapeutics December 19, 2024 OTC Stock Price Synopsis

Various analyses of Relief Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Relief OTC Stock. It can be used to describe the percentage change in the price of Relief Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Relief OTC Stock.
Relief Therapeutics Price Daily Balance Of Power 13.60 
Relief Therapeutics Price Action Indicator 0.31 
Relief Therapeutics Price Rate Of Daily Change 1.16 

Relief Therapeutics December 19, 2024 OTC Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Relief Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Relief Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Relief Stock and then apply it to test your longer-term investment strategies against Relief.

Relief OTC Stock Price History Data

The price series of Relief Therapeutics for the period between Fri, Sep 20, 2024 and Thu, Dec 19, 2024 has a statistical range of 5.14 with a coefficient of variation of 30.5. The price distribution for the period has arithmetic mean of 5.37. The median price for the last 90 days is 5.84. The company completed stock split (3:4) on 3rd of November 2022.
OpenHighLowCloseVolume
12/19/2024
 5.05  5.05  5.00  5.00 
12/17/2024 5.05  5.05  5.00  5.00  442.00 
12/16/2024 4.71  4.92  4.32  4.32  476.00 
12/13/2024 4.43  4.43  4.14  4.17  764.00 
12/12/2024 4.65  4.65  4.65  4.65  1.00 
12/11/2024 4.65  4.65  4.65  4.65  1.00 
12/10/2024 4.65  4.65  4.65  4.65  1.00 
12/09/2024 4.65  4.65  4.65  4.65  1.00 
12/06/2024 4.65  4.65  4.65  4.65  422.00 
12/05/2024 4.75  4.75  4.75  4.75  1.00 
12/04/2024 4.15  4.75  4.15  4.75  5,652 
12/03/2024 5.08  5.08  5.08  5.08  1.00 
12/02/2024 5.10  5.51  5.08  5.08  3,986 
11/29/2024 5.91  6.13  5.91  6.13  337.00 
11/27/2024 5.50  5.75  5.50  5.75  211.00 
11/26/2024 5.90  5.90  5.90  5.90  24.00 
11/25/2024 5.90  5.90  5.90  5.90  226.00 
11/22/2024 5.98  5.98  5.98  5.98  1.00 
11/21/2024 5.95  5.98  5.95  5.98  211.00 
11/20/2024 5.71  5.84  5.70  5.84  553.00 
11/19/2024 4.93  5.67  4.71  5.67  560.00 
11/18/2024 6.10  6.10  5.72  5.84  1,944 
11/15/2024 6.95  6.95  6.95  6.95  422.00 
11/14/2024 7.70  7.70  7.70  7.70  100.00 
11/13/2024 7.50  7.56  7.15  7.15  2,761 
11/12/2024 7.10  7.71  7.10  7.71  1,211 
11/11/2024 7.29  7.60  7.19  7.60  415.00 
11/08/2024 6.50  7.20  6.50  7.20  311.00 
11/07/2024 6.65  7.18  6.65  7.18  611.00 
11/06/2024 7.03  7.03  7.03  7.03  1.00 
11/05/2024 6.66  7.03  6.66  7.03  702.00 
11/04/2024 7.05  7.56  6.61  7.55  862.00 
11/01/2024 6.81  6.81  6.81  6.81  111.00 
10/31/2024 6.27  6.30  6.27  6.30  361.00 
10/30/2024 7.55  7.55  7.55  7.55  1.00 
10/29/2024 7.55  7.55  7.55  7.55  130.00 
10/28/2024 7.25  7.25  7.11  7.20  322.00 
10/25/2024 7.08  7.08  6.79  6.79  323.00 
10/24/2024 6.45  6.45  6.45  6.45  1.00 
10/23/2024 6.45  6.45  6.45  6.45  1.00 
10/22/2024 6.66  6.66  6.45  6.45  300.00 
10/21/2024 7.28  7.28  6.62  6.62  711.00 
10/18/2024 6.63  6.63  6.63  6.63  1.00 
10/17/2024 6.63  6.63  6.63  6.63  1.00 
10/16/2024 6.63  6.63  6.63  6.63  111.00 
10/15/2024 6.40  6.50  6.40  6.50  2,000 
10/14/2024 6.50  6.50  5.62  5.62  632.00 
10/11/2024 5.43  5.64  5.31  5.64  2,005 
10/10/2024 5.70  6.59  5.70  6.59  648.00 
10/09/2024 7.29  7.35  6.94  7.12  2,250 
10/08/2024 4.81  4.81  4.81  4.81  1,262 
10/07/2024 3.45  3.45  3.45  3.45  1,911 
10/04/2024 3.27  3.27  3.27  3.27  111.00 
10/03/2024 2.54  3.13  2.54  3.13  1,350 
10/02/2024 3.41  3.41  3.41  3.41  1.00 
10/01/2024 3.41  3.41  3.41  3.41  711.00 
09/30/2024 3.45  3.45  3.00  3.10  545.00 
09/27/2024 3.60  3.65  3.60  3.65  436.00 
09/26/2024 3.02  3.02  3.02  3.02  1.00 
09/25/2024 3.36  3.36  3.02  3.02  360.00 
09/24/2024 2.58  2.58  2.58  2.58  3,965 

About Relief Therapeutics OTC Stock history

Relief Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Relief is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Relief Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Relief Therapeutics stock prices may prove useful in developing a viable investing in Relief Therapeutics
Relief Therapeutics Holding AG, a biopharmaceutical company, provides patients with therapeutic relief from serious diseases with high unmet medical need in Switzerland, rest of Europe, North America, and internationally. The company was founded in 2013 and is based in Geneva, Switzerland. Relief Therapeutics is traded on OTC Exchange in the United States.

Relief Therapeutics OTC Stock Technical Analysis

Relief Therapeutics technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
A focus of Relief Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Relief Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Share Portfolio Now

   

Share Portfolio

Track or share privately all of your investments from the convenience of any device
All  Next Launch Module

Relief Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Relief Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Relief OTC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Relief to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Relief OTC Stock Analysis

When running Relief Therapeutics' price analysis, check to measure Relief Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Relief Therapeutics is operating at the current time. Most of Relief Therapeutics' value examination focuses on studying past and present price action to predict the probability of Relief Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Relief Therapeutics' price. Additionally, you may evaluate how the addition of Relief Therapeutics to your portfolios can decrease your overall portfolio volatility.